Ann E Kurth1, Freya Spielberg, Charles M Cleland, Barrot Lambdin, David R Bangsberg, Pamela A Frick, Anneleen O Severynen, Marc Clausen, Robert G Norman, David Lockhart, Jane M Simoni, King K Holmes. 1. *New York University College of Nursing, New York, NY; †School of Nursing, Biobehavioral Nursing and Health Systems, University of Washington, Seattle, WA; ‡Research Triangle Institute, San Francisco, CA; Departments of §Global Health; ‖Medicine, University of Washington, Seattle, WA; ¶Pangaea Global AIDS Foundation, Oakland, CA; #University of California, San Francisco, CA; **Harborview Medical Center, HIV-Specialty Clinic Affiliated With UW, Seattle, WA; and ††Department of Psychology, University of Washington, Seattle, WA.
Abstract
OBJECTIVE: Evaluate a computerized intervention supporting antiretroviral therapy (ART) adherence and HIV transmission prevention. DESIGN: Longitudinal randomized controlled trial. SETTINGS: An academic HIV clinic and a community-based organization in Seattle. SUBJECTS: In a total of 240 HIV-positive adults on ART, 209 completed 9-month follow-up (87% retention). INTERVENTION: Randomization to computerized counseling or assessment only, 4 sessions over 9 months. MAIN OUTCOME MEASURES: HIV-1 viral suppression, and self-reported ART adherence and transmission risks, compared using generalized estimating equations. RESULTS: Overall, intervention participants had reduced viral load: mean 0.17 log10 decline, versus 0.13 increase in controls, P = 0.053, and significant difference in ART adherence baseline to 9 months (P = 0.046). Their sexual transmission risk behaviors decreased (odds ratio = 0.55, P = 0.020), a reduction not seen among controls (odds ratio = 1.1, P = 0.664), and a significant difference in change (P = 0.040). Intervention effect was driven by those most in need; among those with detectable virus at baseline (>30 copies/mL, n = 89), intervention effect was mean 0.60 log10 viral load decline versus 0.15 increase in controls, P = 0.034. ART adherence at the final follow-up was 13 points higher among intervention participants versus controls, P = 0.038. CONCLUSIONS:Computerized counseling is promising for integrated ART adherence and safer sex, especially for individuals with problems in these areas. This is the first intervention to report improved ART adherence, viral suppression, and reduced secondary sexual transmission risk behavior.
RCT Entities:
OBJECTIVE: Evaluate a computerized intervention supporting antiretroviral therapy (ART) adherence and HIV transmission prevention. DESIGN: Longitudinal randomized controlled trial. SETTINGS: An academic HIV clinic and a community-based organization in Seattle. SUBJECTS: In a total of 240 HIV-positive adults on ART, 209 completed 9-month follow-up (87% retention). INTERVENTION: Randomization to computerized counseling or assessment only, 4 sessions over 9 months. MAIN OUTCOME MEASURES: HIV-1 viral suppression, and self-reported ART adherence and transmission risks, compared using generalized estimating equations. RESULTS: Overall, intervention participants had reduced viral load: mean 0.17 log10 decline, versus 0.13 increase in controls, P = 0.053, and significant difference in ART adherence baseline to 9 months (P = 0.046). Their sexual transmission risk behaviors decreased (odds ratio = 0.55, P = 0.020), a reduction not seen among controls (odds ratio = 1.1, P = 0.664), and a significant difference in change (P = 0.040). Intervention effect was driven by those most in need; among those with detectable virus at baseline (>30 copies/mL, n = 89), intervention effect was mean 0.60 log10 viral load decline versus 0.15 increase in controls, P = 0.034. ART adherence at the final follow-up was 13 points higher among intervention participants versus controls, P = 0.038. CONCLUSIONS: Computerized counseling is promising for integrated ART adherence and safer sex, especially for individuals with problems in these areas. This is the first intervention to report improved ART adherence, viral suppression, and reduced secondary sexual transmission risk behavior.
Authors: Janet J Myers; Carol Dawson Rose; Starley B Shade; Kimberly A Koester; Andre Maiorana; Faye Malitz; Wayne T Steward; Stephen F Morin Journal: AIDS Behav Date: 2007-06-27
Authors: Sara L C Mackenzie; Ann E Kurth; Freya Spielberg; Anneleen Severynen; C Kevin Malotte; Janet St Lawrence; J Dennis Fortenberry Journal: J Adolesc Health Date: 2007-03-26 Impact factor: 5.012
Authors: Mallory O Johnson; Edwin Charlebois; Stephen F Morin; Robert H Remien; Margaret A Chesney Journal: J Acquir Immune Defic Syndr Date: 2007-12-15 Impact factor: 3.731
Authors: María Luisa Zúñiga; Heather Baldwin; Daniel Uhler; Jesse Brennan; Alisa María Olshefsky; Erin Oliver; William Christopher Mathews Journal: AIDS Behav Date: 2007-06-21
Authors: Paul Gilbert; Daniel Ciccarone; Stuart A Gansky; David R Bangsberg; Kathleen Clanon; Stephen J McPhee; Sophia H Calderón; Alyssa Bogetz; Barbara Gerbert Journal: PLoS One Date: 2008-04-23 Impact factor: 3.240
Authors: Ann E Kurth; John E Sidle; Nok Chhun; John A Lizcano; Stephen M Macharia; Meghan M Garcia; Ann Mwangi; Alfred Keter; Abraham M Siika Journal: AIDS Educ Prev Date: 2019-10
Authors: Gary Marks; Christine O'Daniels; Cynthia Grossman; Nicole Crepaz; Charles E Rose; Unnati Patel; Michael J Stirratt; Lytt I Gardner; Edward R Cachay; William C Mathews; Mari-Lynn Drainoni; Meg Sullivan; Lucy Bradley-Springer; Marla Corwin; Christopher Gordon; Allan Rodriguez; Shireesha Dhanireddy; Thomas P Giordano Journal: AIDS Care Date: 2018-08-16
Authors: Kathryn A Risher; Sunaina Kapoor; Alice Moji Daramola; Gabriela Paz-Bailey; Jacek Skarbinski; Kate Doyle; Kate Shearer; David Dowdy; Eli Rosenberg; Patrick Sullivan; Maunank Shah Journal: AIDS Behav Date: 2017-07